This high purity peptide is available in 2mg, 5mg, and 10mg vials and also in kits, including bacteriostatic water for reconstitution and syringes
The arginate salt form maintains over 95% structural integrity through gastric acid exposure, compared to less than 2% for the acetate form
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
This powerful combination has been meticulously developed for advanced investigation in regenerative biology, accelerated tissue repair, and comprehensive cellular recovery research, offering specialized researchers a profoundly complementary approach to studying complex structural repair and systemic adaptation mechanisms
A vial labeled "5 mg" from one compounder may differ meaningfully from another, raising the practical risk of accidental misdosing even when a patient follows a physician's written protocol